KindlyMD, Inc. NAKA
9.99
0.23
2.36%
as of 25 Sep
- Market cap
- $177.2M
- P/E
- 0.0×
Follow NAKA
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.99 | 32.50 | 31.51 | 109.72 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(24.29) | (6.04) | (9.29) | (16.50) | |
P/B ratio |
0.33 | 0.38 | 0.14 | 0.46 | |
Price to Tangible BV |
0.64 | 0.82 | 0.14 | 0.46 | |
EV/Sales |
1.51 | 24.35 | 22.07 | 97.51 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(1.27) | (2.29) | (2.09) | (11.46) | |
EV/FCF |
(0.09) | (0.14) | (0.07) | (0.28) | |
Quick Ratio |
0.11 | 0.14 | 0.10 | 0.11 | |
Current Ratio |
0.15 | 0.25 | 1.04 | 0.13 | |
Net Debt/EBITDA |
0.46 | 0.28 | 0.11 | 2.32 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.18 | 0.01 | 0.01 | 0.01 | |
Operating CF/Net income |
0.02 | 0.10 | (0.20) | 0.15 | |
Capex/Depreciation |
(0.02) | 14.97 | (6.08) | (798.36) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
39.83% | 639.69% | 1,227.65% | 2,777.25% | |
Intangible Assets out of Total Assets |
0.27 | 0.31 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
6.22% | 60.01% | 24.17% | 554.53% | |
Graham Net Nets |
(2.01) | (1.35) | 0.11 | (0.86) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(907.59%) | (488.69%) | (247.86%) | (103.74%) | |
Free Cash Flow Yield |
(870.81%) | (532.29%) | (1,028.19%) | (322.69%) | |
Revenue per Share |
1.79 | 0.17 | 0.17 | 0.08 | |
Operating CF per Share |
(0.16) | (1.46) | (1.51) | (2.59) | |
Capex per Share |
(0.11) | 1.05 | (2.75) | (126.34) | |
Free Cash Flow per Share |
(0.27) | (0.41) | (4.26) | (128.94) | |
Cash per Share |
0.95 | 2.22 | 4.21 | 4.76 | |
Shareholders Equity per Share |
11.82 | 23.07 | 102.75 | 94.06 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.82 | 23.07 | 102.75 | 94.06 | |
Free Cash Flow |
(5.35) | (6.59) | (21.34) | (654.65) | |
Working Capital |
(152.02) | (188.28) | 7.83 | (187.41) | |
Capital Expenditures |
(2.10) | 16.69 | (13.78) | (641.48) | |
Net Current Asset Value |
(158.65) | (190.27) | 7.47 | (187.81) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.06 | (6.23) | 16.15 | 1,652.45 | |
Net Profit Margin |
(370.79%) | (8,916.21%) | 4,367.47% | (22,162.75%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
5.67 | 6.73 | 2.68 | 3.14 | |
Average Assets |
216.20 | 311.66 | 367.14 | 348.37 | |
Average Common Equity |
122.69 | 184.30 | 258.41 | 240.52 |
Columns are period end dates